Clinical outcomes assessment in multiple sclerosis
Richard A. Rudick(Icahn School of Medicine at Mount Sinai), Ernest Willoughby(Cleveland Clinic), Karl Syndulko, Fred Lublin(Icahn School of Medicine at Mount Sinai), Gary Cutter(Alabama Department of Public Health), Stephen M. Rao(Cleveland Clinic), Stephen C. Reingold(Clinical Research Associates), Jack P. Antel(Montreal Neurological Institute and Hospital), Alan J. Thompson(Queen Mary University of London), John Petkau(National Multiple Sclerosis Society), Aaron Miller, Christian Confavreux(Hôpital Pierre Wertheimer), George W. Ellison(University of California, Los Angeles), Brain Weinshenker(Mayo Clinic), Jill S. Fischer(Cleveland Clinic), Joy Wallenberg(West Los Angeles College)
Cited by 177
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k